Dyslipidemia Management in Chinese Post Stroke Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 5,000
- 试验地点
- 1
- 主要终点
- To observe LDL-C level of China post-stroke patients within 6-12 months from attack
研究概览
简要总结
The purpose of this study is to provide current and reliable data of dyslipidimia management together with control situation of blood pressure and glucose for post-stroke patients within 6-12 months from attack, and also the association between patient characteristics and control rate of lipids in this population.
It is an non-interventional study, no study specified treatment is required.Approximately 5000 post ischemic stroke patients within 6-12 months from attack will enter into the study. Fifty centres from different regions of China will participate in this study.
详细描述
This is a multicentre, cross-sectional, observational study, aiming to investigate the prevalence and control situation of dyslipidimia in China post ischemic stroke patients within 6-12 months from attack. Patients will be screened consecutively, eligible subjects will be interviewed by investigator and finish a questionire during the visit. Investigator will collect relevant medical history, physical exam results and lab test results including blood lipid (i.e. Triglyceride, Total Cholesterol, LDL-C, HDL-C) and glucose(HbA1c if available).Approximately 5000 post ischemic stroke patients within 6-12 months from attack will enter into the study. Fifty centres from different regions of China will participate in this study.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female with age ≥ 18 years
- •Post ischemic stroke patients within 6-12 months from attack
- •written informed consent is provided to participant in the study
排除标准
- •Significant medical or psychological condition that make patients can not finish the questionnaire independently or with the aids of his/her legal representatives
- •The patient is or will be in another clinical study
- •Previous enrolment in the present study
结局指标
主要结局
To observe LDL-C level of China post-stroke patients within 6-12 months from attack
时间窗: Up to 12 months
Investigator will collect lab test results including blood lipid (i.e. Triglyceride, Total Cholesterol, LDL-C, HDL-C) during the patient visit.
To observe control rate of LDL-C of China post-stroke patients within 6-12 months from attack
时间窗: Up to 12 months
次要结局
未报告次要终点